• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

An attempt to establish a new treatment for non-squamous cell carcinoma of the uterine cervix

Research Project

Project/Area Number 17K11265
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Obstetrics and gynecology
Research InstitutionTohoku University

Principal Investigator

SHIMADA Muneaki  東北大学, 未来型医療創成センター, 教授 (40362892)

Co-Investigator(Kenkyū-buntansha) 徳永 英樹  東北大学, 医学系研究科, 准教授 (30595559)
北谷 和之  東北大学, 東北メディカル・メガバンク機構, 講師 (40539235)
永井 智之  東北大学, 医学系研究科, 非常勤講師 (00704298)
Project Period (FY) 2017-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords子宮頸癌 / 組織亜型 / 難治性がん / メタボローム解析 / 化学療法 / 集学的治療 / 個別化医療 / 非扁平上皮癌 / 化学療法感受性 / 放射線感受性
Outline of Final Research Achievements

In an attempt to establish a new treatment for non-squamous carcinoma of the cervix, one of the most refractory gynecologic malignancies, we conducted a clinico-pathological study utilizing real-world data based on a large number of surgical cases and demonstrated "clinic-pathological features based on histological subtypes" that directly lead to appropriate treatment selection. We have identified candidate metabolic profiles to predict prognosis and therapeutic efficacy, and candidate target metabolites associated with therapeutic resistance, using convenient and relatively inexpensive metabolomic analysis.

Academic Significance and Societal Importance of the Research Achievements

組織亜型により子宮頸癌の分子生物学的特徴が異なることは指摘されているものの、組織亜型が子宮頸癌の生存成績に与える影響については一定の見解が得られていないことから、組織亜型やゲノムシグネチャーに基づいた治療法は推奨されていない。
今回の研究成果により、難治性婦人科悪性腫瘍である子宮頸部非扁平上皮癌に着眼した治療の精緻化が実装され、検診事業の促進、ワクチンプログラムの浸透と合わせた「俯瞰的治療戦略」により、子宮頸癌制圧の実現が大きく期待される。

Report

(7 results)
  • 2022 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • 2020 Research-status Report
  • 2019 Research-status Report
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (17 results)

All 2022 2021 2020 2019 2018 2017

All Journal Article (17 results) (of which Int'l Joint Research: 10 results,  Peer Reviewed: 17 results,  Open Access: 16 results)

  • [Journal Article] Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors2022

    • Author(s)
      Shibuya Yusuke、Shimada Muneaki、Tsuji Keita、Shigeta Shogo、Tanase Yasuhito、Matsuo Koji、Yamaguchi Satoshi、Kanao Hiroyuki、Saito Toshiaki、Mikami Mikio
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 52 Pages: 1289-1296

    • DOI

      10.1093/jjco/hyac125

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group2022

    • Author(s)
      Shigeta Shogo、Shimada Muneaki、Tsuji Keita、Nagai Tomoyuki、Tanase Yasuhito、Matsuo Koji、Kamiura Shoji、Iwata Takashi、Yokota Harushige、Mikami Mikio
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 27 Issue: 9 Pages: 1507-1515

    • DOI

      10.1007/s10147-022-02198-6

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.2021

    • Author(s)
      Tsuji K, Shimada M, Takahashi F, Tokunaga H, Deura I, Yamaguchi S, Nakanishi T, Matsuo K, Yaegashi N, Mikami M.
    • Journal Title

      Int J Clin Oncol.

      Volume: 26(8) Issue: 8 Pages: 1541-1552

    • DOI

      10.1007/s10147-021-01938-4

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine.2021

    • Author(s)
      Shimada M, Sato S, Shoji T, Nagao S, Tokunaga H, Sueoka K, Takehara K, Nakamura K, Yamaguchi S, Kigawa J.
    • Journal Title

      Int J Clin Oncol

      Volume: 26 Issue: 7 Pages: 1314-1321

    • DOI

      10.1007/s10147-021-01903-1

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy2021

    • Author(s)
      Miyahara S, Tsuji K, Shimada M, Shibuya Y, Shigeta S, Nagai T, Umezawa R, Tokunaga H, Jingu K, Yaegashi N.
    • Journal Title

      The Tohoku Journal of Experimental Medicine

      Volume: 255 Issue: 4 Pages: 303-313

    • DOI

      10.1620/tjem.255.303

    • NAID

      130008129404

    • ISSN
      0040-8727, 1349-3329
    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.2021

    • Author(s)
      Toyoshima M, Shimada M, Sasaki S, Ishibashi M, Shigeta S, Tsuji K, Nagai T, Tokunaga H, Niikura H, Yaegashi N.
    • Journal Title

      Tohoku J Exp Med.

      Volume: 254(3) Issue: 3 Pages: 145-153

    • DOI

      10.1620/tjem.254.145

    • NAID

      130008061848

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Impact of Histopathological Risk Factors on the Treatment of Stage IB-IIB Uterine Cervical Cancer2020

    • Author(s)
      Shimada Muneaki、Tokunaga Hideki、Kigawa Junzo、Yaegashi Nobuo
    • Journal Title

      The Tohoku Journal of Experimental Medicine

      Volume: 252 Issue: 4 Pages: 339-351

    • DOI

      10.1620/tjem.252.339

    • NAID

      130007953560

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Perioperative treatments for stage IB-IIB uterine cervical cancer2020

    • Author(s)
      Shimada Muneaki、Tokunaga Hideki、Kobayashi Hiroaki、Ishikawa Mitsuya、Yaegashi Nobuo
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 2 Pages: 99-103

    • DOI

      10.1093/jjco/hyz200

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.2020

    • Author(s)
      Matsuzaki S, Klar M, Mikami M, Shimada M, Grubbs BH, Fujiwara K, Roman LD, Matsuo K
    • Journal Title

      Curr Oncol Rep

      Volume: 22(3) Issue: 3 Pages: 28-28

    • DOI

      10.1007/s11912-020-0888-x

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study2019

    • Author(s)
      Matsuo Koji、Shimada Muneaki、Matsuzaki Shinya、Machida Hiroko、Nagase Yoshikazu、Saito Toshiaki、Kamiura Shoji、Iwata Takashi、Sugiyama Toru、Mikami Mikio
    • Journal Title

      Journal of Clinical Medicine

      Volume: 8 Issue: 11 Pages: 1822-1822

    • DOI

      10.3390/jcm8111822

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer2019

    • Author(s)
      Matsuo Koji、Shimada Muneaki、Yamaguchi Satoshi、Matoda Maki、Nakanishi Toru、Kikkawa Fumitaka、Ohmichi Masahide、Okamoto Aikou、Sugiyama Toru、Mikami Mikio
    • Journal Title

      Obstetrics & Gynecology

      Volume: 133 Issue: 6 Pages: 1086-1098

    • DOI

      10.1097/aog.0000000000003280

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.2019

    • Author(s)
      Matsuo K, Shimada M, Nakamura K, Takei Y, Ushijima K, Sumi T, Ohara T, Yahata H, Mikami M, Sugiyama T.
    • Journal Title

      Eur J Sur Oncol

      Volume: - Issue: 8 Pages: 1417-1424

    • DOI

      10.1016/j.ejso.2019.02.019

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Neoadjuvant chemotherapy with taxane and platinum followed by radical hysterectomy for stage IB2-IIB cervical cancer: Impact of histology type on survival.2019

    • Author(s)
      Matsuo K, Shimada M, Yamaguchi S, Kigawa J, Tokunaga H, Tabata T, Kodama J, Kawana K, Mikami M, Sugiyama T.
    • Journal Title

      Journal of Clinical Medicine

      Volume: 30: 8(2) Issue: 2 Pages: 156-169

    • DOI

      10.3390/jcm8020156

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Risk stratification models for peri-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.2018

    • Author(s)
      Matsuo K, Shimada M, Tsuyoshi Saito T, Takehara K, Tokunaga H, Watanabe Y, Todo Y, Morishige K, Mikami M, Sugiyama T.
    • Journal Title

      J Gynecol Oncol.

      Volume: 29 (1):e11. Issue: 1

    • DOI

      10.3802/jgo.2018.29.e11

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Chemoresistance of gastric-type mucinous carcinoma of the uterine cervix: a study of the Sankai Gynecology Study Group.2018

    • Author(s)
      Kojima A, Shimada M, Mikami Y, Nagao S, Takeshima N, Sugiyama T, Teramoto N, Kiyokawa T, Kigawa J, Nishimura R, Sankai Gynecology Study Group (SGSG)
    • Journal Title

      Int J Gynecol Cancer

      Volume: 28(1) Issue: 1 Pages: 99-106

    • DOI

      10.1097/igc.0000000000001145

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.2017

    • Author(s)
      Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, Matsumoto T, Mikami M, Sugiyama T.
    • Journal Title

      Int J Cancer

      Volume: 141 (5) Issue: 5 Pages: 1042-1051

    • DOI

      10.1002/ijc.30793

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer2017

    • Author(s)
      Matsuo Koji、Shimada Muneaki、Yokota Harushige、Satoh Toyomi、Katabuchi Hidetaka、Kodama Shoji、Sasaki Hiroshi、Matsumura Noriomi、Mikami Mikio、Sugiyama Toru
    • Journal Title

      Oncotarget

      Volume: 8 Issue: 63 Pages: 106866-106875

    • DOI

      10.18632/oncotarget.22437

    • NAID

      120007134533

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2017-04-28   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi